SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
NKX2-2
|
ENSG00000125820.5 | NK2 homeobox 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NKX2-2 | hg19_v2_chr20_-_21494654_21494678 | 0.13 | 5.8e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_+_150404904 | 12.07 |
ENST00000521632.1
|
GPX3
|
glutathione peroxidase 3 (plasma) |
chr3_+_189507523 | 5.80 |
ENST00000437221.1
ENST00000392463.2 ENST00000392461.3 ENST00000449992.1 ENST00000456148.1 |
TP63
|
tumor protein p63 |
chr3_+_189507460 | 5.56 |
ENST00000434928.1
|
TP63
|
tumor protein p63 |
chr8_-_49833978 | 5.31 |
ENST00000020945.1
|
SNAI2
|
snail family zinc finger 2 |
chr8_-_49834299 | 5.10 |
ENST00000396822.1
|
SNAI2
|
snail family zinc finger 2 |
chr12_-_28124903 | 4.91 |
ENST00000395872.1
ENST00000354417.3 ENST00000201015.4 |
PTHLH
|
parathyroid hormone-like hormone |
chr16_+_55600580 | 4.76 |
ENST00000457326.2
|
CAPNS2
|
calpain, small subunit 2 |
chr3_-_121379739 | 4.61 |
ENST00000428394.2
ENST00000314583.3 |
HCLS1
|
hematopoietic cell-specific Lyn substrate 1 |
chr3_+_189507432 | 4.33 |
ENST00000354600.5
|
TP63
|
tumor protein p63 |
chr1_-_153363452 | 4.10 |
ENST00000368732.1
ENST00000368733.3 |
S100A8
|
S100 calcium binding protein A8 |
chr5_+_147443534 | 3.49 |
ENST00000398454.1
ENST00000359874.3 ENST00000508733.1 ENST00000256084.7 |
SPINK5
|
serine peptidase inhibitor, Kazal type 5 |
chr2_-_214013353 | 3.47 |
ENST00000451136.2
ENST00000421754.2 ENST00000374327.4 ENST00000413091.3 |
IKZF2
|
IKAROS family zinc finger 2 (Helios) |
chr1_-_161046266 | 3.36 |
ENST00000453926.2
|
PVRL4
|
poliovirus receptor-related 4 |
chr11_+_34654011 | 3.05 |
ENST00000531794.1
|
EHF
|
ets homologous factor |
chr3_-_69249863 | 3.02 |
ENST00000478263.1
ENST00000462512.1 |
FRMD4B
|
FERM domain containing 4B |
chr3_-_196911002 | 2.99 |
ENST00000452595.1
|
DLG1
|
discs, large homolog 1 (Drosophila) |
chrX_+_115567767 | 2.95 |
ENST00000371900.4
|
SLC6A14
|
solute carrier family 6 (amino acid transporter), member 14 |
chr5_+_148206156 | 2.79 |
ENST00000305988.4
|
ADRB2
|
adrenoceptor beta 2, surface |
chr17_-_8059638 | 2.69 |
ENST00000584202.1
ENST00000354903.5 ENST00000577253.1 |
PER1
|
period circadian clock 1 |
chr9_+_71820057 | 2.67 |
ENST00000539225.1
|
TJP2
|
tight junction protein 2 |
chr5_+_154181816 | 2.66 |
ENST00000518677.1
|
LARP1
|
La ribonucleoprotein domain family, member 1 |
chr4_+_160203650 | 2.64 |
ENST00000514565.1
|
RAPGEF2
|
Rap guanine nucleotide exchange factor (GEF) 2 |
chr2_+_102953608 | 2.63 |
ENST00000311734.2
ENST00000409584.1 |
IL1RL1
|
interleukin 1 receptor-like 1 |
chr22_-_43567750 | 2.59 |
ENST00000494035.1
|
TTLL12
|
tubulin tyrosine ligase-like family, member 12 |
chr7_+_2393714 | 2.55 |
ENST00000431643.1
|
EIF3B
|
eukaryotic translation initiation factor 3, subunit B |
chr5_+_82767583 | 2.55 |
ENST00000512590.2
ENST00000513960.1 ENST00000513984.1 ENST00000502527.2 |
VCAN
|
versican |
chr14_-_100841794 | 2.52 |
ENST00000556295.1
ENST00000554820.1 |
WARS
|
tryptophanyl-tRNA synthetase |
chr12_+_69202795 | 2.50 |
ENST00000539479.1
ENST00000393415.3 ENST00000523991.1 ENST00000543323.1 ENST00000393416.2 |
MDM2
|
MDM2 oncogene, E3 ubiquitin protein ligase |
chr9_+_71819927 | 2.48 |
ENST00000535702.1
|
TJP2
|
tight junction protein 2 |
chr4_-_99578789 | 2.47 |
ENST00000511651.1
ENST00000505184.1 |
TSPAN5
|
tetraspanin 5 |
chr13_-_86373536 | 2.46 |
ENST00000400286.2
|
SLITRK6
|
SLIT and NTRK-like family, member 6 |
chr11_-_128894053 | 2.44 |
ENST00000392657.3
|
ARHGAP32
|
Rho GTPase activating protein 32 |
chr2_+_208104497 | 2.42 |
ENST00000430494.1
|
AC007879.7
|
AC007879.7 |
chr3_+_190281229 | 2.40 |
ENST00000453359.1
|
IL1RAP
|
interleukin 1 receptor accessory protein |
chrX_+_152953505 | 2.39 |
ENST00000253122.5
|
SLC6A8
|
solute carrier family 6 (neurotransmitter transporter), member 8 |
chr7_-_24957699 | 2.38 |
ENST00000441059.1
ENST00000415162.1 |
OSBPL3
|
oxysterol binding protein-like 3 |
chr1_-_22222764 | 2.36 |
ENST00000439717.2
ENST00000412328.1 |
HSPG2
|
heparan sulfate proteoglycan 2 |
chr1_+_117963209 | 2.35 |
ENST00000449370.2
|
MAN1A2
|
mannosidase, alpha, class 1A, member 2 |
chr18_+_55888767 | 2.31 |
ENST00000431212.2
ENST00000586268.1 ENST00000587190.1 |
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
chr18_-_68004529 | 2.29 |
ENST00000578633.1
|
RP11-484N16.1
|
RP11-484N16.1 |
chr6_+_32937083 | 2.24 |
ENST00000456339.1
|
BRD2
|
bromodomain containing 2 |
chr5_+_82767487 | 2.14 |
ENST00000343200.5
ENST00000342785.4 |
VCAN
|
versican |
chr17_+_61086917 | 2.12 |
ENST00000424789.2
ENST00000389520.4 |
TANC2
|
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 |
chr10_-_4720301 | 2.10 |
ENST00000449712.1
|
LINC00704
|
long intergenic non-protein coding RNA 704 |
chr12_+_14572070 | 2.10 |
ENST00000545769.1
ENST00000428217.2 ENST00000396279.2 ENST00000542514.1 ENST00000536279.1 |
ATF7IP
|
activating transcription factor 7 interacting protein |
chr8_-_101962777 | 2.10 |
ENST00000395951.3
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta |
chr2_-_151344172 | 2.05 |
ENST00000375734.2
ENST00000263895.4 ENST00000454202.1 |
RND3
|
Rho family GTPase 3 |
chr15_+_79165222 | 2.03 |
ENST00000559930.1
|
MORF4L1
|
mortality factor 4 like 1 |
chr5_+_156887027 | 1.98 |
ENST00000435489.2
ENST00000311946.7 |
NIPAL4
|
NIPA-like domain containing 4 |
chr5_-_160365601 | 1.97 |
ENST00000518580.1
ENST00000518301.1 |
RP11-109J4.1
|
RP11-109J4.1 |
chr1_+_19967014 | 1.96 |
ENST00000428975.1
|
NBL1
|
neuroblastoma 1, DAN family BMP antagonist |
chr3_+_41241596 | 1.94 |
ENST00000450969.1
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa |
chr6_-_150212029 | 1.82 |
ENST00000529948.1
ENST00000357183.4 ENST00000367363.3 |
RAET1E
|
retinoic acid early transcript 1E |
chr13_+_25875785 | 1.79 |
ENST00000381747.3
|
NUPL1
|
nucleoporin like 1 |
chr19_+_58193388 | 1.73 |
ENST00000596085.1
ENST00000594684.1 |
ZNF551
AC003006.7
|
zinc finger protein 551 Uncharacterized protein |
chr11_-_8892900 | 1.73 |
ENST00000526155.1
ENST00000524757.1 ENST00000527392.1 ENST00000534665.1 ENST00000525169.1 ENST00000527516.1 ENST00000533471.1 |
ST5
|
suppression of tumorigenicity 5 |
chr9_+_131447342 | 1.69 |
ENST00000409104.3
|
SET
|
SET nuclear oncogene |
chr12_+_69202975 | 1.68 |
ENST00000544561.1
ENST00000393410.1 ENST00000299252.4 ENST00000360430.2 ENST00000517852.1 ENST00000545204.1 ENST00000393413.3 ENST00000350057.5 ENST00000348801.2 ENST00000478070.1 |
MDM2
|
MDM2 oncogene, E3 ubiquitin protein ligase |
chr10_-_104913367 | 1.67 |
ENST00000423468.2
|
NT5C2
|
5'-nucleotidase, cytosolic II |
chr2_+_192542879 | 1.65 |
ENST00000409510.1
|
NABP1
|
nucleic acid binding protein 1 |
chr14_-_100841670 | 1.64 |
ENST00000557297.1
ENST00000555813.1 ENST00000557135.1 ENST00000556698.1 ENST00000554509.1 ENST00000555410.1 |
WARS
|
tryptophanyl-tRNA synthetase |
chr17_+_66521936 | 1.63 |
ENST00000592800.1
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha |
chr2_+_17721230 | 1.61 |
ENST00000457525.1
|
VSNL1
|
visinin-like 1 |
chr17_+_66511224 | 1.58 |
ENST00000588178.1
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha |
chr1_-_227505289 | 1.56 |
ENST00000366765.3
|
CDC42BPA
|
CDC42 binding protein kinase alpha (DMPK-like) |
chr5_+_140800638 | 1.54 |
ENST00000398587.2
ENST00000518882.1 |
PCDHGA11
|
protocadherin gamma subfamily A, 11 |
chr7_-_84121858 | 1.54 |
ENST00000448879.1
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
chr14_-_82000140 | 1.52 |
ENST00000555824.1
ENST00000557372.1 ENST00000336735.4 |
SEL1L
|
sel-1 suppressor of lin-12-like (C. elegans) |
chr4_-_99578776 | 1.51 |
ENST00000515287.1
|
TSPAN5
|
tetraspanin 5 |
chr4_-_36246060 | 1.50 |
ENST00000303965.4
|
ARAP2
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
chr11_-_11374904 | 1.47 |
ENST00000528848.2
|
CSNK2A3
|
casein kinase 2, alpha 3 polypeptide |
chr12_+_76653611 | 1.46 |
ENST00000550380.1
|
RP11-54A9.1
|
RP11-54A9.1 |
chr1_-_202936394 | 1.44 |
ENST00000367249.4
|
CYB5R1
|
cytochrome b5 reductase 1 |
chrM_+_12331 | 1.43 |
ENST00000361567.2
|
MT-ND5
|
mitochondrially encoded NADH dehydrogenase 5 |
chr17_-_38859996 | 1.42 |
ENST00000264651.2
|
KRT24
|
keratin 24 |
chr19_-_51568324 | 1.41 |
ENST00000595547.1
ENST00000335422.3 ENST00000595793.1 ENST00000596955.1 |
KLK13
|
kallikrein-related peptidase 13 |
chr10_+_98741041 | 1.40 |
ENST00000286067.2
|
C10orf12
|
chromosome 10 open reading frame 12 |
chr6_-_27440460 | 1.40 |
ENST00000377419.1
|
ZNF184
|
zinc finger protein 184 |
chr19_+_7445850 | 1.40 |
ENST00000593531.1
|
CTD-2207O23.3
|
Rho guanine nucleotide exchange factor 18 |
chr16_-_69166031 | 1.39 |
ENST00000398235.2
ENST00000520529.1 |
CHTF8
|
CTF8, chromosome transmission fidelity factor 8 homolog (S. cerevisiae) |
chr1_-_31538517 | 1.39 |
ENST00000440538.2
ENST00000423018.2 ENST00000424085.2 ENST00000426105.2 ENST00000257075.5 ENST00000373747.3 ENST00000525843.1 ENST00000373742.2 |
PUM1
|
pumilio RNA-binding family member 1 |
chr7_+_18548878 | 1.39 |
ENST00000456174.2
|
HDAC9
|
histone deacetylase 9 |
chr12_+_76653682 | 1.38 |
ENST00000553247.1
|
RP11-54A9.1
|
RP11-54A9.1 |
chr10_+_13628921 | 1.38 |
ENST00000378572.3
|
PRPF18
|
pre-mRNA processing factor 18 |
chr3_-_33686925 | 1.37 |
ENST00000485378.2
ENST00000313350.6 ENST00000487200.1 |
CLASP2
|
cytoplasmic linker associated protein 2 |
chr2_-_214014959 | 1.37 |
ENST00000442445.1
ENST00000457361.1 ENST00000342002.2 |
IKZF2
|
IKAROS family zinc finger 2 (Helios) |
chr3_+_63953415 | 1.36 |
ENST00000484332.1
|
ATXN7
|
ataxin 7 |
chr2_+_192543694 | 1.33 |
ENST00000435931.1
|
NABP1
|
nucleic acid binding protein 1 |
chr2_+_192543153 | 1.30 |
ENST00000425611.2
|
NABP1
|
nucleic acid binding protein 1 |
chr17_+_74372662 | 1.28 |
ENST00000591651.1
ENST00000545180.1 |
SPHK1
|
sphingosine kinase 1 |
chr22_-_36220420 | 1.28 |
ENST00000473487.2
|
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chrX_-_32173579 | 1.26 |
ENST00000359836.1
ENST00000343523.2 ENST00000378707.3 ENST00000541735.1 ENST00000474231.1 |
DMD
|
dystrophin |
chr16_+_23194033 | 1.26 |
ENST00000300061.2
|
SCNN1G
|
sodium channel, non-voltage-gated 1, gamma subunit |
chr13_-_99630233 | 1.24 |
ENST00000376460.1
ENST00000442173.1 |
DOCK9
|
dedicator of cytokinesis 9 |
chr4_-_119759795 | 1.17 |
ENST00000419654.2
|
SEC24D
|
SEC24 family member D |
chr10_+_63808970 | 1.16 |
ENST00000309334.5
|
ARID5B
|
AT rich interactive domain 5B (MRF1-like) |
chr13_-_41240717 | 1.16 |
ENST00000379561.5
|
FOXO1
|
forkhead box O1 |
chr5_-_124084493 | 1.16 |
ENST00000509799.1
|
ZNF608
|
zinc finger protein 608 |
chr11_+_64949899 | 1.15 |
ENST00000531068.1
ENST00000527699.1 ENST00000533909.1 ENST00000527323.1 |
CAPN1
|
calpain 1, (mu/I) large subunit |
chr7_+_18548924 | 1.14 |
ENST00000524023.1
|
HDAC9
|
histone deacetylase 9 |
chr5_+_108083517 | 1.14 |
ENST00000281092.4
ENST00000536402.1 |
FER
|
fer (fps/fes related) tyrosine kinase |
chr2_+_219110149 | 1.13 |
ENST00000456575.1
|
ARPC2
|
actin related protein 2/3 complex, subunit 2, 34kDa |
chr1_+_104293028 | 1.13 |
ENST00000370079.3
|
AMY1C
|
amylase, alpha 1C (salivary) |
chr20_-_36152914 | 1.12 |
ENST00000397131.1
|
BLCAP
|
bladder cancer associated protein |
chr4_+_3076388 | 1.11 |
ENST00000355072.5
|
HTT
|
huntingtin |
chr6_-_11779014 | 1.10 |
ENST00000229583.5
|
ADTRP
|
androgen-dependent TFPI-regulating protein |
chr2_-_70409953 | 1.09 |
ENST00000419381.1
|
C2orf42
|
chromosome 2 open reading frame 42 |
chr8_-_99954788 | 1.08 |
ENST00000523601.1
|
STK3
|
serine/threonine kinase 3 |
chr5_+_179135246 | 1.08 |
ENST00000508787.1
|
CANX
|
calnexin |
chr11_-_7698453 | 1.07 |
ENST00000524608.1
|
CYB5R2
|
cytochrome b5 reductase 2 |
chrX_+_123095546 | 1.07 |
ENST00000371157.3
ENST00000371145.3 ENST00000371144.3 |
STAG2
|
stromal antigen 2 |
chr4_+_87928140 | 1.07 |
ENST00000307808.6
|
AFF1
|
AF4/FMR2 family, member 1 |
chr3_-_69101461 | 1.06 |
ENST00000543976.1
|
TMF1
|
TATA element modulatory factor 1 |
chr13_+_25875662 | 1.05 |
ENST00000381736.3
ENST00000463407.1 ENST00000381718.3 |
NUPL1
|
nucleoporin like 1 |
chr9_+_123970052 | 1.03 |
ENST00000373823.3
|
GSN
|
gelsolin |
chr10_+_13628933 | 1.02 |
ENST00000417658.1
ENST00000320054.4 |
PRPF18
|
pre-mRNA processing factor 18 |
chr1_-_154150651 | 1.01 |
ENST00000302206.5
|
TPM3
|
tropomyosin 3 |
chr6_+_158733692 | 1.00 |
ENST00000367094.2
ENST00000367097.3 |
TULP4
|
tubby like protein 4 |
chr4_+_144303093 | 1.00 |
ENST00000505913.1
|
GAB1
|
GRB2-associated binding protein 1 |
chr5_-_110848253 | 0.97 |
ENST00000505803.1
ENST00000502322.1 |
STARD4
|
StAR-related lipid transfer (START) domain containing 4 |
chr14_-_100841930 | 0.96 |
ENST00000555031.1
ENST00000553395.1 ENST00000553545.1 ENST00000344102.5 ENST00000556338.1 ENST00000392882.2 ENST00000553934.1 |
WARS
|
tryptophanyl-tRNA synthetase |
chr1_-_9953295 | 0.95 |
ENST00000377258.1
|
CTNNBIP1
|
catenin, beta interacting protein 1 |
chr7_+_133615169 | 0.94 |
ENST00000541309.1
|
EXOC4
|
exocyst complex component 4 |
chr13_+_113863858 | 0.94 |
ENST00000375440.4
|
CUL4A
|
cullin 4A |
chr15_+_79165296 | 0.93 |
ENST00000558746.1
ENST00000558830.1 ENST00000559345.1 |
MORF4L1
|
mortality factor 4 like 1 |
chr4_+_56719782 | 0.93 |
ENST00000381295.2
ENST00000346134.7 ENST00000349598.6 |
EXOC1
|
exocyst complex component 1 |
chr7_+_115862858 | 0.93 |
ENST00000393481.2
|
TES
|
testis derived transcript (3 LIM domains) |
chr15_-_60683326 | 0.92 |
ENST00000559350.1
ENST00000558986.1 ENST00000560389.1 |
ANXA2
|
annexin A2 |
chr7_+_102715573 | 0.91 |
ENST00000434153.1
|
ARMC10
|
armadillo repeat containing 10 |
chr5_+_34757309 | 0.90 |
ENST00000397449.1
|
RAI14
|
retinoic acid induced 14 |
chr5_+_125758865 | 0.90 |
ENST00000542322.1
ENST00000544396.1 |
GRAMD3
|
GRAM domain containing 3 |
chr2_+_171034646 | 0.89 |
ENST00000409044.3
ENST00000408978.4 |
MYO3B
|
myosin IIIB |
chr6_+_45296048 | 0.88 |
ENST00000465038.2
ENST00000352853.5 ENST00000541979.1 ENST00000371438.1 |
RUNX2
|
runt-related transcription factor 2 |
chr15_-_42840961 | 0.87 |
ENST00000563454.1
ENST00000397130.3 ENST00000570160.1 ENST00000323443.2 |
LRRC57
|
leucine rich repeat containing 57 |
chrY_+_15418467 | 0.86 |
ENST00000595988.1
|
AC010877.1
|
Uncharacterized protein |
chr3_+_38206975 | 0.84 |
ENST00000446845.1
ENST00000311806.3 |
OXSR1
|
oxidative stress responsive 1 |
chr16_+_53241854 | 0.83 |
ENST00000565803.1
|
CHD9
|
chromodomain helicase DNA binding protein 9 |
chrX_-_130037162 | 0.82 |
ENST00000432489.1
|
ENOX2
|
ecto-NOX disulfide-thiol exchanger 2 |
chr8_+_26150628 | 0.82 |
ENST00000523925.1
ENST00000315985.7 |
PPP2R2A
|
protein phosphatase 2, regulatory subunit B, alpha |
chr6_-_80247105 | 0.82 |
ENST00000369846.4
|
LCA5
|
Leber congenital amaurosis 5 |
chr1_+_67395922 | 0.81 |
ENST00000401042.3
ENST00000355356.3 |
MIER1
|
mesoderm induction early response 1, transcriptional regulator |
chr13_+_111766897 | 0.81 |
ENST00000317133.5
|
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7 |
chr6_-_80247140 | 0.81 |
ENST00000392959.1
ENST00000467898.3 |
LCA5
|
Leber congenital amaurosis 5 |
chr11_-_107729887 | 0.80 |
ENST00000525815.1
|
SLC35F2
|
solute carrier family 35, member F2 |
chr12_+_25205446 | 0.80 |
ENST00000557489.1
ENST00000354454.3 ENST00000536173.1 |
LRMP
|
lymphoid-restricted membrane protein |
chr5_+_159656437 | 0.79 |
ENST00000402432.3
|
FABP6
|
fatty acid binding protein 6, ileal |
chr8_-_141810634 | 0.78 |
ENST00000521986.1
ENST00000523539.1 ENST00000538769.1 |
PTK2
|
protein tyrosine kinase 2 |
chr1_-_110155671 | 0.77 |
ENST00000351050.3
|
GNAT2
|
guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2 |
chr5_+_125758813 | 0.77 |
ENST00000285689.3
ENST00000515200.1 |
GRAMD3
|
GRAM domain containing 3 |
chr17_+_75315654 | 0.77 |
ENST00000590595.1
|
SEPT9
|
septin 9 |
chr11_+_9406169 | 0.76 |
ENST00000379719.3
ENST00000527431.1 |
IPO7
|
importin 7 |
chr1_+_84629976 | 0.76 |
ENST00000446538.1
ENST00000370684.1 ENST00000436133.1 |
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta |
chr5_+_118668846 | 0.76 |
ENST00000513374.1
|
TNFAIP8
|
tumor necrosis factor, alpha-induced protein 8 |
chr15_-_38519066 | 0.76 |
ENST00000561320.1
ENST00000561161.1 |
RP11-346D14.1
|
RP11-346D14.1 |
chr9_+_129097520 | 0.73 |
ENST00000436593.3
|
MVB12B
|
multivesicular body subunit 12B |
chr12_+_19389814 | 0.73 |
ENST00000536974.1
|
PLEKHA5
|
pleckstrin homology domain containing, family A member 5 |
chr9_+_137218362 | 0.72 |
ENST00000481739.1
|
RXRA
|
retinoid X receptor, alpha |
chr17_+_75315534 | 0.71 |
ENST00000590294.1
ENST00000329047.8 |
SEPT9
|
septin 9 |
chr3_-_69101413 | 0.71 |
ENST00000398559.2
|
TMF1
|
TATA element modulatory factor 1 |
chr13_-_36944307 | 0.70 |
ENST00000355182.4
|
SPG20
|
spastic paraplegia 20 (Troyer syndrome) |
chr4_-_140477928 | 0.69 |
ENST00000274031.3
|
SETD7
|
SET domain containing (lysine methyltransferase) 7 |
chr12_-_10875831 | 0.69 |
ENST00000279550.7
ENST00000228251.4 |
YBX3
|
Y box binding protein 3 |
chr14_-_31856397 | 0.69 |
ENST00000538864.2
ENST00000550366.1 |
HEATR5A
|
HEAT repeat containing 5A |
chr13_-_33112956 | 0.68 |
ENST00000505213.1
|
N4BP2L2
|
NEDD4 binding protein 2-like 2 |
chr13_+_111855414 | 0.67 |
ENST00000375737.5
|
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7 |
chr6_+_45296391 | 0.66 |
ENST00000371436.6
ENST00000576263.1 |
RUNX2
|
runt-related transcription factor 2 |
chr10_-_104262460 | 0.66 |
ENST00000446605.2
ENST00000369905.4 ENST00000545684.1 |
ACTR1A
|
ARP1 actin-related protein 1 homolog A, centractin alpha (yeast) |
chr2_-_160472052 | 0.66 |
ENST00000437839.1
|
BAZ2B
|
bromodomain adjacent to zinc finger domain, 2B |
chr10_+_102295616 | 0.65 |
ENST00000299163.6
|
HIF1AN
|
hypoxia inducible factor 1, alpha subunit inhibitor |
chr11_+_65266507 | 0.65 |
ENST00000544868.1
|
MALAT1
|
metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) |
chr18_-_43684230 | 0.63 |
ENST00000592989.1
ENST00000589869.1 |
ATP5A1
|
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle |
chr6_+_32936353 | 0.62 |
ENST00000374825.4
|
BRD2
|
bromodomain containing 2 |
chr8_-_18666360 | 0.62 |
ENST00000286485.8
|
PSD3
|
pleckstrin and Sec7 domain containing 3 |
chr8_+_94767109 | 0.62 |
ENST00000409623.3
ENST00000453906.1 ENST00000521517.1 |
TMEM67
|
transmembrane protein 67 |
chr5_-_179047881 | 0.60 |
ENST00000521173.1
|
HNRNPH1
|
heterogeneous nuclear ribonucleoprotein H1 (H) |
chr12_+_32552451 | 0.60 |
ENST00000534526.2
|
FGD4
|
FYVE, RhoGEF and PH domain containing 4 |
chr8_-_122653630 | 0.60 |
ENST00000303924.4
|
HAS2
|
hyaluronan synthase 2 |
chr6_+_44355257 | 0.59 |
ENST00000371477.3
|
CDC5L
|
cell division cycle 5-like |
chr8_+_11666649 | 0.59 |
ENST00000528643.1
ENST00000525777.1 |
FDFT1
|
farnesyl-diphosphate farnesyltransferase 1 |
chr20_+_56964169 | 0.59 |
ENST00000475243.1
|
VAPB
|
VAMP (vesicle-associated membrane protein)-associated protein B and C |
chr12_+_25205155 | 0.58 |
ENST00000550945.1
|
LRMP
|
lymphoid-restricted membrane protein |
chr2_+_183582774 | 0.58 |
ENST00000537515.1
|
DNAJC10
|
DnaJ (Hsp40) homolog, subfamily C, member 10 |
chr22_+_42086547 | 0.58 |
ENST00000402966.1
|
C22orf46
|
chromosome 22 open reading frame 46 |
chr7_-_17598506 | 0.57 |
ENST00000451792.1
|
AC017060.1
|
AC017060.1 |
chr5_+_125759140 | 0.57 |
ENST00000543198.1
|
GRAMD3
|
GRAM domain containing 3 |
chr12_+_41136144 | 0.57 |
ENST00000548005.1
ENST00000552248.1 |
CNTN1
|
contactin 1 |
chr3_+_142838091 | 0.57 |
ENST00000309575.3
|
CHST2
|
carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2 |
chr6_+_158957431 | 0.56 |
ENST00000367090.3
|
TMEM181
|
transmembrane protein 181 |
chr1_-_207095324 | 0.56 |
ENST00000530505.1
ENST00000367091.3 ENST00000442471.2 |
FAIM3
|
Fas apoptotic inhibitory molecule 3 |
chr7_+_16700806 | 0.55 |
ENST00000446596.1
ENST00000438834.1 |
BZW2
|
basic leucine zipper and W2 domains 2 |
chr3_+_69811858 | 0.55 |
ENST00000433517.1
|
MITF
|
microphthalmia-associated transcription factor |
chr1_-_155880672 | 0.53 |
ENST00000609492.1
ENST00000368322.3 |
RIT1
|
Ras-like without CAAX 1 |
chr12_+_100750846 | 0.53 |
ENST00000323346.5
|
SLC17A8
|
solute carrier family 17 (vesicular glutamate transporter), member 8 |
chr1_+_180601139 | 0.52 |
ENST00000367590.4
ENST00000367589.3 |
XPR1
|
xenotropic and polytropic retrovirus receptor 1 |
chr1_-_182573514 | 0.52 |
ENST00000367558.5
|
RGS16
|
regulator of G-protein signaling 16 |
chr2_+_238969728 | 0.51 |
ENST00000416757.1
|
SCLY
|
selenocysteine lyase |
chr3_+_179280668 | 0.51 |
ENST00000429709.2
ENST00000450518.2 ENST00000392662.1 ENST00000490364.1 |
ACTL6A
|
actin-like 6A |
chr2_+_74229812 | 0.51 |
ENST00000305799.7
|
TET3
|
tet methylcytosine dioxygenase 3 |
chr19_-_3971050 | 0.51 |
ENST00000545797.2
ENST00000596311.1 |
DAPK3
|
death-associated protein kinase 3 |
chr5_-_150521192 | 0.50 |
ENST00000523714.1
ENST00000521749.1 |
ANXA6
|
annexin A6 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 15.7 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
3.5 | 10.4 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
1.7 | 12.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.4 | 4.2 | GO:1904404 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
0.9 | 2.8 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.9 | 5.1 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.8 | 2.4 | GO:0071030 | nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
0.8 | 2.4 | GO:1902598 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
0.7 | 5.0 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.5 | 5.1 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.5 | 3.5 | GO:0002786 | regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
0.5 | 1.9 | GO:1904793 | glial cell fate determination(GO:0007403) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of chromatin-mediated maintenance of transcription(GO:1904499) positive regulation of chromatin-mediated maintenance of transcription(GO:1904501) regulation of euchromatin binding(GO:1904793) |
0.4 | 2.7 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
0.4 | 1.3 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.4 | 1.7 | GO:1903045 | neural crest cell migration involved in sympathetic nervous system development(GO:1903045) |
0.4 | 2.5 | GO:0060005 | vestibular reflex(GO:0060005) |
0.4 | 2.0 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.4 | 1.1 | GO:0010877 | lipid transport involved in lipid storage(GO:0010877) |
0.4 | 1.1 | GO:0050904 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) diapedesis(GO:0050904) |
0.4 | 2.6 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.4 | 1.1 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.4 | 1.8 | GO:2000843 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
0.3 | 2.7 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.3 | 2.4 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.3 | 2.3 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.3 | 3.0 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
0.3 | 2.8 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.3 | 0.8 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.3 | 4.7 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.2 | 3.9 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.2 | 0.7 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.2 | 1.0 | GO:0044855 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.2 | 1.0 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.2 | 1.2 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.2 | 0.9 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.2 | 1.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.2 | 0.7 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.2 | 1.2 | GO:0019075 | virus maturation(GO:0019075) |
0.2 | 0.5 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
0.2 | 0.7 | GO:0052363 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
0.2 | 4.7 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.2 | 4.9 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.6 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.6 | GO:1990637 | response to prolactin(GO:1990637) |
0.1 | 3.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 1.9 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 0.9 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
0.1 | 1.3 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 2.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.4 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.1 | 2.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 1.5 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.5 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
0.1 | 2.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 1.4 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.1 | 0.7 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.1 | 1.8 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.1 | 1.3 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.1 | 3.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.7 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
0.1 | 0.9 | GO:0097338 | response to clozapine(GO:0097338) |
0.1 | 1.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 1.7 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 1.8 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.3 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.1 | 0.9 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.1 | 4.0 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 1.1 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.7 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.1 | 1.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 1.1 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.1 | 0.2 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 2.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.8 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 1.9 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.8 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.1 | 1.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.7 | GO:2000767 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) positive regulation of cytoplasmic translation(GO:2000767) |
0.1 | 1.4 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.3 | GO:0072560 | glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) |
0.1 | 0.4 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 0.3 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.1 | 0.6 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.1 | 1.2 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 0.4 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.0 | 0.9 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 1.5 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.4 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 7.0 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 3.0 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.0 | 1.6 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.0 | 0.3 | GO:0001781 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) common myeloid progenitor cell proliferation(GO:0035726) |
0.0 | 1.1 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.0 | 0.8 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 4.3 | GO:0042795 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.0 | 0.5 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.4 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.0 | 0.2 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
0.0 | 0.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.0 | 0.3 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.9 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.0 | 0.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 1.6 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 1.0 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.0 | 0.7 | GO:0061458 | reproductive system development(GO:0061458) |
0.0 | 0.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.1 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.0 | 0.6 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.5 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 1.5 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.0 | 1.1 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.0 | 1.2 | GO:0016577 | histone demethylation(GO:0016577) |
0.0 | 0.3 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.3 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.0 | 0.4 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.1 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.0 | 0.6 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.2 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 2.3 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.0 | 0.6 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.0 | 0.5 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.2 | GO:0006006 | glucose metabolic process(GO:0006006) |
0.0 | 0.2 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.0 | 1.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.2 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.4 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
0.0 | 0.5 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.1 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
0.0 | 0.5 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 2.1 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 1.3 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.0 | 2.1 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.1 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.0 | 0.5 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.0 | 0.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.0 | 0.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.1 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.4 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 2.4 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
0.5 | 4.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.5 | 3.5 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.4 | 1.1 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.4 | 1.9 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.3 | 2.8 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 1.9 | GO:0070369 | Scrib-APC-beta-catenin complex(GO:0034750) beta-catenin-TCF7L2 complex(GO:0070369) |
0.2 | 0.9 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.2 | 3.0 | GO:0097025 | lateral loop(GO:0043219) MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 0.5 | GO:0097451 | basilar dendrite(GO:0097441) glial limiting end-foot(GO:0097451) |
0.2 | 2.7 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 4.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 1.8 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 1.3 | GO:0016013 | syntrophin complex(GO:0016013) |
0.1 | 0.7 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.1 | 0.4 | GO:0098844 | postsynaptic endocytic zone membrane(GO:0098844) |
0.1 | 0.5 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 1.4 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 0.9 | GO:0002177 | manchette(GO:0002177) |
0.1 | 1.8 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 2.4 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 13.0 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 1.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.9 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 3.6 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.1 | 1.0 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 1.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.6 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.9 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 1.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 1.0 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.0 | 0.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 1.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 1.5 | GO:0031105 | septin complex(GO:0031105) |
0.0 | 8.4 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 5.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.6 | GO:0000974 | Prp19 complex(GO:0000974) DNA replication factor A complex(GO:0005662) |
0.0 | 2.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.6 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.7 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 2.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 13.7 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 2.7 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 2.1 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.7 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 4.2 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.0 | 0.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 1.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.4 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 3.2 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 1.4 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 1.3 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.2 | GO:0005688 | U6 snRNP(GO:0005688) |
0.0 | 2.7 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 4.3 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 1.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 3.6 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 1.9 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.3 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.3 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 3.5 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 5.0 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 1.4 | GO:0016363 | nuclear matrix(GO:0016363) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.2 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
1.0 | 15.7 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.9 | 2.8 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.9 | 2.6 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.9 | 5.1 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.8 | 2.4 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.6 | 2.4 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.6 | 4.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.6 | 12.0 | GO:0008430 | selenium binding(GO:0008430) |
0.6 | 1.7 | GO:0050146 | nucleoside phosphotransferase activity(GO:0050146) |
0.5 | 2.4 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 1.0 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.2 | 0.7 | GO:0030626 | U12 snRNA binding(GO:0030626) |
0.2 | 3.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 2.6 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.2 | 0.6 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.2 | 1.3 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.2 | 0.7 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.2 | 2.0 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 2.5 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.2 | 2.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.6 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 2.3 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 1.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 3.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.5 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.1 | 4.9 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.5 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 2.6 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.4 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
0.1 | 0.4 | GO:0070538 | oleic acid binding(GO:0070538) |
0.1 | 0.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 4.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 3.0 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 3.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.6 | GO:0043532 | angiostatin binding(GO:0043532) |
0.1 | 0.3 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
0.1 | 2.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 1.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 2.5 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 3.5 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 2.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.6 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 0.8 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 1.9 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 1.0 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 2.8 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 1.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.7 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.7 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 2.9 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 1.2 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 2.8 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.4 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 1.8 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 1.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 1.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.8 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.8 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 8.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 3.2 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.9 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.0 | 0.3 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 1.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 1.7 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 4.9 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 2.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 1.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.6 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 1.2 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 3.2 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 1.3 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.5 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.0 | 0.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.8 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.0 | 0.7 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.2 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.5 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 0.4 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 0.2 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.4 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.2 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 2.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.4 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 0.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 3.6 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.1 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 8.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 4.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.2 | 15.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 4.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 12.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 2.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 2.9 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 6.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 6.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 3.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 3.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 2.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 5.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 3.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 1.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 3.9 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 5.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 1.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 2.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 1.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 2.0 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 1.9 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.2 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 0.5 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 1.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.4 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 1.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.7 | PID P53 REGULATION PATHWAY | p53 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 7.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 3.9 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 6.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 5.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 3.0 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 3.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 1.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 4.1 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 1.3 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 3.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 1.7 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 2.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 1.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 2.1 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 1.9 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 3.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 1.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 2.7 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.9 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 1.2 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 1.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 2.4 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 2.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 1.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 1.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 1.0 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.0 | 2.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 3.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 2.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 1.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.6 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 1.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 1.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 1.4 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.7 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 1.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.6 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.3 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.0 | 1.1 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |